We are live on ! Find out more
ORI

Oak Ridge Investments Portfolio holdings

AUM $1.77B
1-Year Est. Return 63.16%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+63.16%
3 Year Est. Return
+207.98%
5 Year Est. Return
+285.85%
10 Year Est. Return
+1,406.09%
AUM
$1.81B
AUM Growth
+$46.7M
Cap. Flow
-$117M
Cap. Flow %
-6.44%
Top 10 Hldgs %
23.31%
Holding
167
New
11
Increased
22
Reduced
127
Closed
6

Top Buys

Rank Stock Value
1
PODD icon
Insulet
PODD
+$12.3M
2
EVH icon
Evolent Health
EVH
+$9.38M
3
CBM
Cambrex Corporation
CBM
+$9.24M
4
ARWR icon
Arrowhead Research
ARWR
+$6.23M
5
NOMD icon
Nomad Foods
NOMD
+$5.88M

Top Sells

Rank Stock Value
1
NVRO
NEVRO CORP.
NVRO
+$18.3M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$10.6M
3
MXL icon
MaxLinear
MXL
+$9.45M
4
ABMD
Abiomed Inc
ABMD
+$9.37M
5
RSPP
RSP Permian, Inc.
RSPP
+$7.6M

Sector Composition

Rank Sector Weight
1 Technology 23.84%
2 Healthcare 21.94%
3 Industrials 14.87%
4 Consumer Discretionary 13.92%
5 Consumer Staples 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLAB icon
76
Silicon Laboratories
SLAB
$7.23B
$9.42M 0.52%
102,645
-9,361
-8% -$915K
ABBV icon
77
AbbVie
ABBV
$435B
$9.35M 0.52%
98,866
-4,041
-4% -$383K
CTSH icon
78
Cognizant
CTSH
$26B
$9.35M 0.52%
121,168
-6,697
-5% -$524K
NFLX icon
79
Netflix
NFLX
$309B
$8.66M 0.48%
231,410
-12,900
-5% -$468K
TVTX icon
80
Travere Therapeutics
TVTX
$5.78B
$8.47M 0.47%
294,842
-35,012
-11% -$1M
SUPN icon
81
Supernus Pharmaceuticals
SUPN
$2.77B
$8.26M 0.46%
163,956
-17,327
-10% -$856K
MIME
82
DELISTED
Mimecast Limited
MIME
$8.23M 0.45%
196,522
-12,667
-6% -$515K
SRPT icon
83
Sarepta Therapeutics
SRPT
$1.77B
$7.83M 0.43%
48,449
-77,258
-61% -$10.6M
ELF icon
84
e.l.f. Beauty
ELF
$5.81B
$7.82M 0.43%
614,593
-75,279
-11% -$1.04M
HOMB icon
85
Home BancShares
HOMB
$6.18B
$7.74M 0.43%
353,279
-23,696
-6% -$551K
NEWR
86
DELISTED
New Relic, Inc.
NEWR
$7.65M 0.42%
81,180
-6,944
-8% -$719K
PYPL icon
87
PayPal
PYPL
$50.5B
$7.45M 0.41%
84,769
-4,476
-5% -$394K
CORT icon
88
Corcept Therapeutics
CORT
$12B
$7.34M 0.41%
523,810
-65,570
-11% -$916K
ARWR icon
89
Arrowhead Research
ARWR
$12.4B
$7.27M 0.4%
+379,374
New +$6.23M
UL icon
90
Unilever
UL
$136B
$7.09M 0.39%
114,661
-4,943
-4% -$312K
FIS icon
91
Fidelity National Information Services
FIS
$22.1B
$6.93M 0.38%
63,519
-3,043
-5% -$328K
QTNA
92
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
$6.92M 0.38%
374,925
-20,815
-5% -$354K
EOG icon
93
EOG Resources
EOG
$70.7B
$6.56M 0.36%
51,435
-2,979
-5% -$362K
KLAC icon
94
KLA
KLAC
$259B
$6.17M 0.34%
606,160
-37,600
-6% -$411K
LITE icon
95
Lumentum
LITE
$69.3B
$6.14M 0.34%
102,379
-3,029
-3% -$181K
DBVT
96
DBV Technologies
DBVT
$847M
$5.78M 0.32%
25,711
-761
-3% -$155K
AVGO icon
97
Broadcom
AVGO
$2.04T
$5.74M 0.32%
232,640
-17,930
-7% -$402K
TWOU
98
DELISTED
2U Inc
TWOU
$5.64M 0.31%
2,501
-299
-11% -$739K
IT icon
99
Gartner
IT
$11.7B
$5.41M 0.3%
34,150
-1,312
-4% -$190K
PEN icon
100
Penumbra
PEN
$12.8B
$5.27M 0.29%
35,231
-3,527
-9% -$494K
2 3
4
5 6

Similar funds

CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Oak Ridge Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oak Ridge Investments held 167 positions worth $1.81B, up 2.6% from $1.76B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oak Ridge Investments withdrew a net $117M in Q3 2018, closing 6 positions and reducing 127 holdings. Its most notable exit was NEVRO CORP., an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oak Ridge Investments opened a new position in Insulet worth $13.9M.

  • Oak Ridge Investments's largest Q3 2018 buy was Insulet: 130,935 shares worth $13.9M.
  • Oak Ridge Investments added most to Nomad Foods in Q3 2018, an estimated $5.88M increase.
  • Oak Ridge Investments's biggest Q3 2018 reduction was Sarepta Therapeutics, cutting an estimated $10.6M.
  • Oak Ridge Investments fully exited NEVRO CORP. in Q3 2018, selling an estimated $18.3M.
  • Oak Ridge Investments's ten largest holdings make up 23% of its $1.81B portfolio in Q3 2018.
  • Oak Ridge Investments opened 11 new positions and closed 6 in Q3 2018.
  • Oak Ridge Investments's portfolio value rose 2.6% quarter-over-quarter to $1.81B.

Based on Oak Ridge Investments's 13F filing for Q3 2018, filed 7 Nov 2018.